Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
LIEBEL-FLARSHEIM COMPANY LLC
🇺🇸
United States
Country
🇺🇸
United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications
Phase 4
Completed
Conditions
Diagnostic Imaging
Interventions
Drug: Xenetix
Drug: Visipaque
Subscribe
First Posted Date
2006-07-04
Last Posted Date
2013-04-09
Lead Sponsor
Guerbet
Target Recruit Count
145
Registration Number
NCT00347022
Locations
🇫🇷
CHU Charles Nicolle, Rouen, France
Subscribe
Prev
1
2
3
4
5
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy